PREDICTOM Highlights the Power of Partnership and Public Involvement at Alzheimer Europe Conference 2026

Transforming health through collaboration

According to Dr. Blomberg, health innovation is a "team sport". He highlighted that the major health challenges facing society, including Alzheimer's disease, are too complex for any single organisation or sector to tackle alone. IHI therefore brings together expertise from academia, industry, patient organisations, hospitals, regulators and public authorities to accelerate the translation of research into real-world impact.

PREDICTOM exemplifies this approach. The project combines expertise from healthcare providers, universities, patient organisations, technology companies and industry partners to develop innovative approaches for the early detection and management of Alzheimer's disease. This multidisciplinary structure helps ensure that project results can move beyond scientific publications and contribute to improvements in everyday clinical practice and patient care.

Putting patients and the public at the centre

A central theme of Dr. Blomberg's message was the vital role of patients, carers and civil society organisations in research and innovation. Across IHI projects, more than 100 patient and civil society organisations are directly involved as project partners, while many others contribute through advisory groups and committees.

He emphasised that people with lived experience provide unique knowledge that cannot be generated elsewhere. Their perspectives help researchers understand which symptoms have the greatest impact on daily life, whether research protocols are practical for participants, and how health data should be used and governed.

These principles are deeply embedded within PREDICTOM. Through initiatives such as the Public Ambassador Group, Public Involvement Pool, WiseAge (Norway) and Consejo de Oro (Spain), people affected by dementia have contributed to study design, participant-facing materials, dissemination activities and the development of home-based assessment approaches. Their involvement helps ensure that PREDICTOM remains relevant, accessible and focused on outcomes that matter to individuals and families.

A shared ambition for earlier dementia detection

PREDICTOM's goal of improving the early detection and management of Alzheimer's disease is closely aligned with IHI's wider ambition to transform health across the entire care pathway, from prevention and early diagnosis to treatment and improved outcomes.

The conference session highlighted how collaboration across sectors, combined with meaningful patient and public involvement, can help accelerate innovation and increase its real-world impact. As PREDICTOM moves forward, these principles will remain central to the project's efforts to bring dementia detection closer to home and improve the lives of people at risk of Alzheimer's disease.